These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3669333)

  • 21. Reduction in multi-lineage and erythroid progenitors distinguishes myelodysplastic syndromes from non-malignant cytopenias.
    Vercauteren SM; Bashashati A; Wu D; Brinkman RR; Eaves C; Eaves A; Karsan A
    Leuk Res; 2009 Dec; 33(12):1636-42. PubMed ID: 19414193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes.
    Neukirchen J; Blum S; Kuendgen A; Strupp C; Aivado M; Haas R; Aul C; Gattermann N; Germing U
    Eur J Haematol; 2009 Nov; 83(5):477-82. PubMed ID: 19548919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The myelodysplastic syndromes.
    Nguyen PL
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):675-91. PubMed ID: 19577164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic value of histology and immunohistochemistry in myelodysplastic syndromes.
    Horny HP; Sotlar K; Valent P
    Leuk Res; 2007 Dec; 31(12):1609-16. PubMed ID: 17604834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of the haematologic spectrum of myelodysplastic syndrome.
    Kini J; Khadilkar UN; Dayal JP
    Indian J Pathol Microbiol; 2001 Jan; 44(1):9-12. PubMed ID: 12561987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myelodysplastic syndromes.
    Misra RC
    J Indian Med Assoc; 1992 May; 90(5):134-5. PubMed ID: 1517622
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening of myelodysplastic syndrome using cell population data obtained from an automatic hematology analyzer.
    Kim H; Han E; Lee HK; Kim Y; Han K
    Int J Lab Hematol; 2021 Apr; 43(2):e54-e57. PubMed ID: 33215843
    [No Abstract]   [Full Text] [Related]  

  • 28. [The role of bone marrow stromal cells in apoptosis in myelodysplastic syndrome].
    Yaguchi M; Aizawa M; Toriyama K
    Rinsho Ketsueki; 1996 Jul; 37(7):542-6. PubMed ID: 8779769
    [No Abstract]   [Full Text] [Related]  

  • 29. [Myeloproliferative syndromes].
    Ganser A
    Ther Umsch; 1996 Feb; 53(2):97-102. PubMed ID: 8629270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Might arsenic trioxide be useful in the treatment of advanced myelodysplastic syndromes?
    Donelli A; Chiodino C; Panissidi T; Roncaglia R; Torelli G
    Haematologica; 2000 Sep; 85(9):1002-3. PubMed ID: 10980650
    [No Abstract]   [Full Text] [Related]  

  • 31. An association of polymyalgia rheumatica with myelodysplastic syndromes.
    Kohli M; Bennett RM
    J Rheumatol; 1994 Jul; 21(7):1357-9. PubMed ID: 7966085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
    Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
    Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Myelodysplastic syndromes].
    Matsuda A
    Rinsho Ketsueki; 2009 Mar; 50(3):147-53. PubMed ID: 19352080
    [No Abstract]   [Full Text] [Related]  

  • 35. Erythrophagocytosis by neoplastic cells in a patient with myelodysplastic syndrome.
    Ascani S; Sabattini E; Agostinelli C; Piccaluga PP; Zinzani PL; Pileri SA
    Haematologica; 2004 Apr; 89(4):EIM07. PubMed ID: 15075110
    [No Abstract]   [Full Text] [Related]  

  • 36. Peripheral blood granulocyte-macrophage progenitors in patients with the myelodysplastic syndromes.
    Tennant GB; Jacobs A; Bailey-Wood R
    Exp Hematol; 1986 Dec; 14(11):1063-8. PubMed ID: 3780888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Copper deficiency: an important consideration in the differential diagnosis of myelodysplastic syndrome.
    Fong T; Vij R; Vijayan A; DiPersio J; Blinder M
    Haematologica; 2007 Oct; 92(10):1429-30. PubMed ID: 18024379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Myelodysplastic syndromes: unusual and mild forms].
    Rochant H
    Pathol Biol (Paris); 1997 Sep; 45(7):579-86. PubMed ID: 9404483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Myelodysplastic syndromes].
    Sainty D; Horschowski N; Fossat C; Sampol J
    Ann Biol Clin (Paris); 1985; 43(6):821-30. PubMed ID: 3914223
    [No Abstract]   [Full Text] [Related]  

  • 40. Hemophagocytosis exacerbated by G-CSF/GM-CSF treatment in a patient with myelodysplasia.
    Wang S; Degar BA; Zieske A; Shafi NQ; Rose MG
    Am J Hematol; 2004 Dec; 77(4):391-6. PubMed ID: 15551287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.